Médecins Sans Frontières

TB activists for first time challenge TB drug patent in India

TB activists for first time challenge TB drug patent in India, in bid to prevent Johnson & Johnson from extending monopoly.

Read More →

MSF statement at WHO Executive Board 144th Session: Follow-up to the UN High-Level Meeting on TB

Médecins Sans Frontières (MSF) representatives attended the 144th Session of the World Health Organization (WHO) Executive Board (24 January – 1 February 2019, Geneva, Switzerland) and delivered a statement on the follow-up to the UN High-Level Meeting on TB held in September 2018.

Read More →

Vacancy: Consultant - TB Environmental Scan in Canada

Médecins Sans Frontières (MSF) Canada is looking for a consultant to conduct an environmental scan of the Canadian policy, research, and innovation environment as it pertains to TB drugs, diagnostics, and vaccines; to provide strategic advice to MSF on areas of focus for engaging and shaping the policies and practices that develop and deliver new TB tools.

Read More →

HIV and TB treatment at risk as countries gradually lose Global Fund support

Médecins Sans Frontières calls on Global Fund Board to make urgent changes to prevent drug stock-outs and quality issues.

Read More →

Médecins Sans Frontières calls on Johnson & Johnson to cut key TB drug price in half

Warns high prices of TB drugs restrict people's access to best drug-resistant TB treatment.

Read More →

Global leaders must make tangible commitments at UN High-Level Meeting on TB

Médecins Sans Frontières calls on governments to scale up TB testing and treatment to save more lives today, and make real commitments to develop more effective and easier-to-use tools to defeat TB tomorrow.

Read More →

Médecins Sans Frontières calls for affordable access to critical TB drug bedaquiline

Médecins Sans Frontières to Johnson & Johnson: We need affordable and sustainable supply of bedaquiline.

Read More →

Update on contentious negotiations for the UN High-Level Meeting on TB

South Africa breaks the ‘silence’ period and negotiations are re-opened

Read More →

At last minute, countries pressured to drop language on protecting access to affordable medicines from TB Summit declaration negotiations

New York, 20 July 2018 — Countries negotiating the final declaration text for the first-ever UN High-level Meeting on Tuberculosis in September are being put under significant pressure to drop all references to protecting countries’ rights to take fully-legal actions to access affordable medicines for their people, Médecins Sans Frontières reported learning today.

Read More →

South Africa takes landmark step for access to medicines

MSF applauds effort to ‘take off patent blindfold’ and change patent laws to increase access to affordable medicines

Read More →

Page 1 of 6 · Total posts: 10

1 2 Last→